JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totaling 238,313 shares, a drop of 48.0% from the August 15th total of 457,885 shares. Based on an average daily volume of 27 shares, the days-to-cover ratio is presently 8,826.4 days.
JCR Pharmaceuticals Stock Performance
JCR Pharmaceuticals stock remained flat at $3.33 during mid-day trading on Thursday. The firm has a 50 day moving average price of $3.32 and a two-hundred day moving average price of $3.67. JCR Pharmaceuticals has a 1-year low of $3.15 and a 1-year high of $3.33.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Featured Articles
- Five stocks we like better than JCR Pharmaceuticals
- CoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale
- Micron’s New 512GB Memory Module Deepens Its AI Infrastructure Advantage
- Banc of California Bets on Short-Term Pain
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
